Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients

Testicular germ-cell tumors (TGCT) have been widely recognized for their outstanding survival rates, commonly attributed to their high sensitivity to cisplatin-based therapies. Despite this, a subset of patients develops cisplatin resistance, for whom additional therapeutic options are unsuccessful,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuevas-Estrada, Berenice, Montalvo-Casimiro, Michel, Munguia-Garza, Paulina, Ríos-Rodríguez, Juan Alberto, González-Barrios, Rodrigo, Herrera, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178517/
https://www.ncbi.nlm.nih.gov/pubmed/37175579
http://dx.doi.org/10.3390/ijms24097873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178517/
https://www.ncbi.nlm.nih.gov/pubmed/37175579
http://dx.doi.org/10.3390/ijms24097873

Ejemplares similares